Background Signet ring colorectal cancer (SRC) is a rare histological subtype associated with young patients and worse outcomes. Its incidence is anticipated to increase with the rising rate of early-onset colorectal cancer. There is little literature on the benefit of adjuvant systemic therapy in this patient cohort. Methods A systematic review of the literature was undertaken to evaluate the response of SRC to adjuvant systemic therapy. The study was pre-registered in the PROSPERO database.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile